These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9279973)

  • 1. Clear cell tumors of unknown nature and origin: a systematic approach to diagnosis.
    Nappi O; Mills SE; Swanson PE; Wick MR
    Semin Diagn Pathol; 1997 Aug; 14(3):164-74. PubMed ID: 9279973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Necrotizing myelopathy associated with neoplasia. A clinico-pathological study of 2 cases and a review of the literature].
    Martín Escudero JC; Aparicio Blanco M; Borrego Pintado H; del Villar Negro A; Carretero Sastre JL; Velasco Fernández C
    An Med Interna; 1991 Oct; 8(10):497-500. PubMed ID: 1751690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensively cystic renal neoplasms: cystic nephroma, cystic partially differentiated nephroblastoma, multilocular cystic renal cell carcinoma, and cystic hamartoma of renal pelvis.
    Eble JN; Bonsib SM
    Semin Diagn Pathol; 1998 Feb; 15(1):2-20. PubMed ID: 9503503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesothelioma with clear cell features: an ultrastructural and immunohistochemical study of 20 cases.
    Ordóñez NG
    Hum Pathol; 2005 May; 36(5):465-73. PubMed ID: 15948112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic renal cell carcinoma: biology and clinical behavior.
    Han KR; Janzen NK; McWhorter VC; Kim HL; Pantuck AJ; Zisman A; Figlin RA; Dorey FJ; Said JW; Belldegrun AS
    Urol Oncol; 2004; 22(5):410-4. PubMed ID: 15464922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcomatoid renal cell carcinoma: case report and review of the literature.
    Staelens L; Van Poppel H; Vanuytsel L; Van Oosterom A; Van Damme B; Baert L
    Acta Urol Belg; 1997 Dec; 65(4):39-42. PubMed ID: 9497596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal cell carcinoma with malignant pleural mesothelioma after asbestos exposure: a case report].
    Sawazaki H; Yoshikawa T; Takahashi T; Taki Y; Takeuchi H; Sakai Y
    Hinyokika Kiyo; 2007 Nov; 53(11):805-8. PubMed ID: 18051806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR; Zhai J
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic renal cell carcinoma presenting as multiple pleural tumours.
    Ohnishi H; Abe M; Hamada H; Yokoyama A; Hirayama T; Ito R; Nishimura K; Higaki J
    Respirology; 2005 Jan; 10(1):128-31. PubMed ID: 15691252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of low-grade neuroendocrine tumors of midgut and unknown origin.
    Van Eeden S; Quaedvlieg PF; Taal BG; Offerhaus GJ; Lamers CB; Van Velthuysen ML
    Hum Pathol; 2002 Nov; 33(11):1126-32. PubMed ID: 12454818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology of diffuse malignant pleural mesothelioma.
    Corson JM
    Semin Thorac Cardiovasc Surg; 1997 Oct; 9(4):347-55. PubMed ID: 9352951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinomas with papillary architecture and clear cell components: the utility of immunohistochemical and cytogenetical analyses in differential diagnosis.
    Gobbo S; Eble JN; Maclennan GT; Grignon DJ; Shah RB; Zhang S; Martignoni G; Brunelli M; Cheng L
    Am J Surg Pathol; 2008 Dec; 32(12):1780-6. PubMed ID: 18779729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic evaluation of malignant pleural mesothelioma.
    Chirieac LR; Corson JM
    Semin Thorac Cardiovasc Surg; 2009; 21(2):121-4. PubMed ID: 19822283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity.
    Gobbo S; Eble JN; Grignon DJ; Martignoni G; MacLennan GT; Shah RB; Zhang S; Brunelli M; Cheng L
    Am J Surg Pathol; 2008 Aug; 32(8):1239-45. PubMed ID: 18594469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant neoplasms of unknown primary site with metastases to the bone marrow].
    Lalowicz I
    Pol Tyg Lek; 1988 May; 43(22):715-7. PubMed ID: 3226981
    [No Abstract]   [Full Text] [Related]  

  • 19. Fine needle aspiration using improved agar microbiopsy is highly concordant with renal mass final diagnosis and subclassification.
    Schieven LW; Smedts F; Hopman AH; van der Wijk J; Nijman RJ; de Jong IJ
    J Urol; 2009 Dec; 182(6):2590-3. PubMed ID: 19836783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic renal cell carcinoma to the thyroid gland: a clinicopathologic study of 36 cases.
    Heffess CS; Wenig BM; Thompson LD
    Cancer; 2002 Nov; 95(9):1869-78. PubMed ID: 12404280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.